StartUPDATES: New developments for healthcare startups
Read about new developments from Stellar Health, Paige, venBio, and more.
StartUPDATES: New developments from healthcare startups
Read about new developments from Blue Therapeutics, Docbot, Sema4, and Deep Lens.
At ViVE 2024, Panelists Share Prior Authorization Progress and Frustration in Payer Insights Program
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
Biotech and medical device companies raise $913M in a five-IPO week
The five life sciences IPOs this week continues the steady march companies are making to the public markets this year. This week's activity follows a first quarter that Renaissance Capital calculates was the busiest for newly public companies since 2000. Healthcare IPOs continued to dominate the stock offerings.
Serimmune CEO: Leveraging the functional antibody repertoire will transform healthcare
In response to emailed questions, the CEO and CTO talk about the immune intelligence startup's Human Immunity Map — a growing database of immune interactions that can support the development of multiplex diagnostics, vaccines and therapeutics.
Cellino Biotech developing tech to help scale stem cell therapies
Cellino Biotech CEO and Co-founder Dr. Nabiha Saklayen talked about the formation of the company and its goal to make stem cell therapies accessible for patients.
More healthcare startups go public through SPACs — but will they succeed?
More healthcare startups are choosing to go public through mergers with special-purpose acquisition companies— publicly-traded shell companies created with the purpose of taking a private company public. But as the number of SPACs searching for targets increases, will the SPAC bubble burst?
Unlocking Transparency in PBM Pricing
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
StartUPDATES: New developments from healthcare startups
Check out new developments from healthcare startups including Bind, ChromaCode and more.
StartUPDATES: New developments from healthcare startups
Read about new developments and milestones in the journey of healthcare startups from Truvian Sciences, NeuroFlow and more.
StartUPDATES: New developments from healthcare startups
Read about new developments from healthcare startups including HealCo, Eikonoklastes, Sidecar Health and more.
Meet biopharma finalists for MedCity virtual INVEST event: Register now for Earlybird tickets while they last
MedCity News will host its INVEST conference online the week of July 20. These five biopharma companies will take part in the INVEST Pitch Perfect startup competition.
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Funding roundup: Health kiosk-maker raises $30M from Babylon Health
Higi, a company that makes health kiosks for use in grocery stores, raised $30 million in funding from Babylon Health. Read more about companies that raised funding this week.
Founders’ story: Libera Bio
In an interview with MedCity News, the founder and CSO of Spanish biotech startup Libera Bio talked about her company's ambitions to apply its precision medicine technologies for the treatment of different types of cancer.
Funding roundup: Pandion Therapeutics raises $80M for autoimmune disease treatment
Despite continued economic impacts from the Covid-19 pandemic, biotechnology companies and VC firms raised significant amounts of funding this week. For example, Massachusetts-based Pandion Therapeutics closed $80 million in funding to develop a therapeutic designed to treat autoimmune diseases.
The power of patient voice in clinical trial design
The increased patient-centric focus in drug development by the FDA is highly encouraging and expected to become more mainstream and legislated.
Healthcare IPOs in 2019: The rise of digital health and biopharma unicorns (Updated)
A new eBook from MedCity News spotlights some of the more interesting deals and trends this year across digital health and biopharma.